Equivalent effects of nicardipine and captopril on urinary albumin excretion of type 2, non-insulin-dependent diabetic subjects with mild to moderate hypertension

Therapie

Volumn 51, Issue 1, 1996, Pages 41-47

  Bouhanick, Béatrice ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Angiotensin converting enzyme inhibitors; Calcium antagonists; Captopril; Diabetes; Hypertensioin; Microalbuminuria; Nicardipine

Indexed keywords

ALBUMIN; CAPTOPRIL; CREATININE; NICARDIPINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; EDEMA; FEMALE; FLUSHING; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ALBUMINURIA; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CAPTOPRIL; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NICARDIPINE;

EID: 0029870518     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Marre M, Bouhanick B, Berrut G. Microalbuminuria Curr Opin Nephrol Hypertens 1994; 3: 558-563.
2. Lewis EJ, Hunsiker LG, Bain RP et al. for the Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462
3. Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. BMJ 1991; 302: 210-216.
4. Chan JCN, Cockram CS, Nicholls MG et al. Comparison of enalapril and nifedipine in treating non-insulin-dependent diabetes associated with hypertension: one year analysis. BMJ 1992; 305: 981-985.
5. Ravid M, Savin H, Jutrin I et al. Long-term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118: 577-581.
6. Gall MA, Rossing P, Skott P et al. Prevalence of micro and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patient. Diabetologia 1991; 34: 655-661.
7. Parving HH, Jensen HA, Mogensen CE et al. Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974; i: 1190-1192.
8. Marre M, Sassano P, Corvol P et al. Microalbuminuria in uncomplicated essential hypertension and its reduction by antihypertensive treatment. Diabete Metab 1988; 14: 232-234.
9. Christensen CK. Rapidly reversible albumin and β2-microglobulin hyperexcretion in recent severe essential hypertension. J Hypertens 1983; 1: 45-51.
10. Marre M, Claudel JP, Ciret P et al. Laser immunonephelometry for routine quantification of urinary albumin excretion. Clin Chem 1987; 33: 209-213.
11. Mogensen CE, Chachati A, Christensen CK et al. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985-86; 9: 85-95.
12. Cockfroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
13. Goldstein DE, Little RR, England JD et al. Methods for quantitating glycosylated hemoglobins: high-performance liquid chromatography and thiobarbituric acid colorimetry. In: Clarke WL, Larner J, Pohl SL, eds, Methods in diabetes research, Vol. 2: clinical methods. New-York: Wiley, 1986: 475-504.
14. Westlake WJ. Statistical aspects of comparative biovailability trials. Biometrics 1979; 35: 273-280.
15. Passa Ph, Leblanc H, Marre M. Effects of enalapril in insulin-dependent diabetic subjects with mild to moderate uncomplicated hypertension. Diabetes Care 1987; 10: 200-204.
16. Passa Ph, Marre M, Leblanc H. Traitement de l'hypertension artérielle chez les diabétiques. Presse Med 1985; 14: 2242-2244.
17. Bigazzi R, Bianchi S, Campese V M et al. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992; 61: 94-97.
18. Bigazzi R, Bianchi S, Baldari D et al. Microalbuminuria in salt-sensitive patients: a marker for renal and cardiovascular risk factors. Hypertension 1994; 23: 195-199.
19. Bjorck S, Nyberg G, Mulec H et al. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. BMJ 1986; 293: 471-474.
20. Björk S, Mulec H, Johnsen SA et al. Renal protective effect of enalapril in diabetic nephropathy. BMJ 1992; 304: 339-343.
21. Trost BN, Weidmann P. Effects of calcium antagonists on glucose homeostasis and serum lipids in non-diabetic and diabetic subjects. J Hypertens 1987; 5 (suppl 4): S81-S104.